LitCovid-sentences  

PMC:7396557 / 74074-76267 JSONTXT 9 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T548 0-168 Sentence denotes Clinical research by Wen Long et al. randomly divided 60 severe COVID-19 patients into routine treatment (n = 20), XBJI 50 ml (n = 20), and XBJI 100 ml (n = 20) groups.
T549 169-341 Sentence denotes On the basis of conventional treatment, XBJI (50 ml) was injected twice a day for 7 days in the XBJI 50 ml group, or 100 ml twice a day for 7 days in the XBJI 100 ml group.
T550 342-478 Sentence denotes After treatment, the white blood cell count (WBC) and lymphocyte count (LYM) of the three groups increased, while CRP and ESR decreased.
T551 479-609 Sentence denotes Compared with the routine treatment group, the WBC count in the XBJI 100 ml group after treatment significantly increased (×109/L:
T552 610-752 Sentence denotes 7.12 ± 0.55 vs. 5.67 ± 0.51, p < 0.05), and the levels of CRP and ESR in the XBJI 50 ml and 100 ml groups significantly decreased [CRP (mg/L):
T553 753-803 Sentence denotes 32.3 ± 4.6, 28.0 ± 6.2 vs. 37.3 ± 5.9; ESR (mm/h):
T554 804-857 Sentence denotes 45.9 ± 5.7, 40.5 ± 7.4 vs. 55.3 ± 6.6, all p < 0.05].
T555 858-1008 Sentence denotes Compared with the XBJI 50 ml group, the increase of WBC, and the decrease of CRP and ESR were more significant in the XBJI 100 ml group [WBC (×109/L):
T556 1009-1049 Sentence denotes 7.12 ± 0.55 vs. 5.82 ± 0.49; CRP (mg/L):
T557 1050-1088 Sentence denotes 28.0 ± 6.2 vs. 32.3 ± 4.6; ESR (mm/h):
T558 1089-1130 Sentence denotes 40.5 ± 7.4 vs. 45.9 ± 5.7, all p < 0.05].
T559 1131-1177 Sentence denotes The APACHE II score of three groups decreased.
T560 1178-1377 Sentence denotes In the XBJI 100 ml group, the APACHE II score after treatment was significantly lower than those in the routine treatment and XBJI 50 ml groups (12.3 ± 1.5 vs. 16.5 ± 1.6, 15.9 ± 1.4, both p < 0.05).
T561 1378-1634 Sentence denotes After treatment, the 2019-nCoV nucleic acid test in the three groups partly turned negative: nine cases in the routine treatment group, eight cases in the XBJI 50 ml group and nine cases in the XBJI 100 ml group, with no significant differences (p > 0.05).
T562 1635-1712 Sentence denotes The conditions of patients in the three groups were improved after treatment.
T563 1713-1936 Sentence denotes Eight cases in the routine treatment group were transformed into common type and one case into critical type; nine cases and 12 cases in the XBJI 50 ml and 100 ml groups, respectively, were transformed into the common type.
T564 1937-2063 Sentence denotes Patients in the XBJI 100 ml group improved more obviously than in the XBJI 50 ml and routine treatment groups (both p < 0.05).
T565 2064-2193 Sentence denotes The XBJI injection can effectively improve the inflammatory markers and prognosis of severe COVID-19 patients (Wen et al., 2020).